Vedolizumab (Entyvio®) trial results for crohn’s disease
Asit Parikh, MD, SVP, and head of the Gastrointestinal Therapeutic Area at Takeda Pharmaceutical Company Limited discusses new data presented at the 15t...
819 articles
Asit Parikh, MD, SVP, and head of the Gastrointestinal Therapeutic Area at Takeda Pharmaceutical Company Limited discusses new data presented at the 15t...
Paul Limburg, a gastroenterology consultant at the Mayo Clinic, and CMO for screening at Exact Sciences, and co-author of this study discusses the resul...
Angela Nicholas, M.D., a Fight Colorectal Cancer board member, and advocate discusses new guidelines from the American Cancer Society that has recommend...
Jones, a comic book artist, discusses his journey living with a myeloproliferative neoplasm, a type of rare blood cancer, that was diagnosed 10 years ag...
Research scientist at Kaiser Permanente Division of Research, Dr. Learn more on Health Professional Radio.
John Temperato, CEO of RDD Pharma and what will be 9 Meters Biopharma, discusses GI diseases, current treatments, why there are still unmet needs for ...
Jeff Sharman of Willamette Valley Cancer Institute and Research Center and Nichole Fisher, RN, BSN, discuss recent research presented at the 2019 Americ...
Scot Ebbinghaus discusses the recent (Jan 2020) FDA approval of Merck's KEYTRUDA® (pembrolizumab) for patients with BCG-unresponsive, high-risk, non-...
Celebrity fitness trainer Anna Kaiser, Founder of AKT, partnered with Lilly in October 2018 to create "The Thriver Movement" She is kicking off the n...
Alison Corcoran, EVP and Chief Marketing Officer at DentaQuest, discusses the gaps in dental care in the U.S., the future of oral health in this country...